Mentioned in this article
Vincerx Pharma Inc (VINC) is near the top in its industry group according to InvestorsObserver. VINC gets an overall rating of 59. That means it scores higher than 59 percent of stocks. Vincerx Pharma Inc gets a 71 rank in the Biotechnology industry. Biotechnology is number 29 out of 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What’s Happening With Vincerx Pharma Inc Stock Today?
Vincerx Pharma Inc (VINC) stock is higher by 2.77% while the S&P 500 is down -0.27% as of 12:50 PM on Monday, Apr 17. VINC has risen $0.03 from the previous closing price of $0.98 on volume of 40,703 shares. Over the past year the S&P 500 is lower by -6.03% while VINC is down -63.93%. VINC lost -$3.11 per share the over the last 12 months.
Click Here to get the full Stock Report for Vincerx Pharma Inc stock.